Stay updated on Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section expanded to add numerous new sites across the US, Canada, Europe, and other regions, while several locations were removed. A revision tag v3.3.3 is also introduced.SummaryDifference3%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe Publications section now distinguishes between volunteer-provided publications and those automatically filled from PubMed. It also records Revision: v3.3.2.SummaryDifference0.4%

- Check48 days agoChange DetectedDeletion of the government funding and NIH operating status notice that previously informed users about potential delays and where to check status (cc.nih.gov, opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedNo substantive differences detected between the old and new screenshots. The Study Details page content and structure appear unchanged.SummaryDifference0.3%

- Check91 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference2%

- Check98 days agoChange DetectedAppended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.SummaryDifference0.3%

Stay in the know with updates to Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.